Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis

OBJECTIVE: The aim of this study was to investigate the effect of dapagliflozin (DAPA) on the rate of heart failure rehospitalization in patients with acute myocardial infarction (AMI) and type 2 diabetes mellitus (T2DM). METHODS: AMI patients with T2DM from CZ-AMI registry between January 2017 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Lipeng, Cai, Dabei, Chi, Boyu, Xiao, Tingting, Zou, Ailin, Wang, Yu, Chen, Qianwen, Gu, Qingqing, Wang, Qingjie, Ji, Yuan, Sun, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276777/
https://www.ncbi.nlm.nih.gov/pubmed/37099214
http://dx.doi.org/10.1007/s00228-023-03495-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276777/
https://www.ncbi.nlm.nih.gov/pubmed/37099214
http://dx.doi.org/10.1007/s00228-023-03495-3

Ejemplares similares